Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1186/s41937-021-00070-4 http://scihub22266oqcxt.onion/10.1186/s41937-021-00070-4 33968811!8094977!33968811     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Swiss+J+Econ+Stat 2021 ; 157 (1): 2 Nephropedia Template TP {{tp|p=33968811|t=2021. Firms participation in the Swiss COVID-19 loan programme |pdf=|usr=}}{{33968811}} gab.com Text Firms participation in the Swiss COVID-19 loan programme JO: Swiss J Econ Stat http://www.kidney.de/pget.php?&tw=1&pmid=33968811 #FOAvip This paper analyses the determinants of firm participation in the Swiss COVID-19 loan programme, which aims to bridge firms' liquidity shortfalls that have resulted from the pandemic. State-guaranteed COVID-19 loans are widely used by Swiss firms, with 20% of all firms participating, resulting in a sizeable programme of 2.4% of GDP. We use a comprehensive dataset to study the determinants of firm participation. Our results can be summarised as follows. First, participation was largely driven by the exposure of a firm to lockdown restrictions and to the intensity of the virus in the specific region. Second, we show that firms associated with lower liquidity ratios had a significantly higher probability of participating in the programme. Third, we find no clear evidence that firm indebtedness affected participation in the programme and no evidence that pre-existing potential "zombie firms" participated more strongly in the loan programme. Fourth, we show that the programme reached younger and smaller firms, which could be financially more vulnerable as they are less likely to obtain outside finance during a crisis. Overall, we conclude that given its objective, the programme appears to be successful. Twit Text FOAVip Firms participation in the Swiss COVID-19 loan programme ????Swiss J Econ Stat http://www.kidney.de/pget.php?&tw=1&pmid=33968811 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33968811 #FOAvip English Wikipedia <ref>{{Cite pmid|33968811}}</ref> Firms participation in the Swiss COVID-19 loan programme #MMPMID33968811 Fuhrer LM; Ramelet MA; Tenhofen J Swiss J Econ Stat 2021[]; 157 (1): 2 PMID33968811show ga This paper analyses the determinants of firm participation in the Swiss COVID-19 loan programme, which aims to bridge firms' liquidity shortfalls that have resulted from the pandemic. State-guaranteed COVID-19 loans are widely used by Swiss firms, with 20% of all firms participating, resulting in a sizeable programme of 2.4% of GDP. We use a comprehensive dataset to study the determinants of firm participation. Our results can be summarised as follows. First, participation was largely driven by the exposure of a firm to lockdown restrictions and to the intensity of the virus in the specific region. Second, we show that firms associated with lower liquidity ratios had a significantly higher probability of participating in the programme. Third, we find no clear evidence that firm indebtedness affected participation in the programme and no evidence that pre-existing potential "zombie firms" participated more strongly in the loan programme. Fourth, we show that the programme reached younger and smaller firms, which could be financially more vulnerable as they are less likely to obtain outside finance during a crisis. Overall, we conclude that given its objective, the programme appears to be successful. äFirms participation in the Swiss COVID-19 loan programme (epmc).pdf DeepDyve Pubget Overpricing